• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匹莫范色林与维持性电休克治疗联合应用:帕金森病精神病的一种新方法。

Combined Pimavanserin and Maintenance Electroconvulsive Therapy: A Novel Approach to Parkinson's Disease Psychosis.

作者信息

Imlay Riley K, Alsayed Majd, Starcher Madison, Tager Alfred, Griffith James

机构信息

Psychiatry, West Virginia University School of Medicine, Charleston, USA.

Psychiatry, Charleston Area Medical Center, Charleston, USA.

出版信息

Cureus. 2024 Jul 11;16(7):e64316. doi: 10.7759/cureus.64316. eCollection 2024 Jul.

DOI:10.7759/cureus.64316
PMID:39130906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316412/
Abstract

Parkinson's disease (PD) is among the most common neurodegenerative diseases. Parkinson's disease psychosis (PDP) is a potential psychiatric manifestation of PD that is associated with increased morbidity and mortality. The treatment of PD with concomitant PDP is challenging as standard-of-care medication to improve motor symptoms can cause or exacerbate PDP. In this case report, we present an atypical presentation of a 70-year-old female who developed PDP only four years after her initial PD diagnosis, much earlier than the established average. Treatment was particularly complex as her PDP symptoms were refractory to PD medication reduction and oral antipsychotics, yet her PD motor symptoms were well controlled with a deep brain stimulator (DBS). We discuss a combination of pimavanserin and maintenance electroconvulsive therapy (ECT) as a safe and efficacious treatment modality which has led to remission of her PDP while DBS continues to provide adequate management of her PD symptoms. This case improves upon the early recognition of PDP and outlines a unique treatment modality not well described in the literature. This is the only case that demonstrates the efficacy of combining pimavanserin and ECT for refractory PDP in a patient with a DBS.

摘要

帕金森病(PD)是最常见的神经退行性疾病之一。帕金森病精神病(PDP)是PD的一种潜在精神表现,与发病率和死亡率增加相关。PD合并PDP的治疗具有挑战性,因为改善运动症状的标准治疗药物可导致或加重PDP。在本病例报告中,我们介绍了一名70岁女性的非典型表现,她在首次诊断为PD仅四年后就出现了PDP,比既定的平均时间早得多。治疗特别复杂,因为她的PDP症状对减少PD药物和口服抗精神病药物无效,而她的PD运动症状通过深部脑刺激器(DBS)得到了很好的控制。我们讨论了匹莫范色林和维持性电休克治疗(ECT)联合使用作为一种安全有效的治疗方式,该方式已使她的PDP得到缓解,同时DBS继续对她的PD症状提供充分管理。该病例改善了对PDP的早期识别,并概述了一种文献中未充分描述的独特治疗方式。这是唯一一例证明匹莫范色林和ECT联合治疗对接受DBS治疗的难治性PDP患者有效的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e67/11316412/e90a11e410f0/cureus-0016-00000064316-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e67/11316412/e90a11e410f0/cureus-0016-00000064316-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e67/11316412/e90a11e410f0/cureus-0016-00000064316-i01.jpg

相似文献

1
Combined Pimavanserin and Maintenance Electroconvulsive Therapy: A Novel Approach to Parkinson's Disease Psychosis.匹莫范色林与维持性电休克治疗联合应用:帕金森病精神病的一种新方法。
Cureus. 2024 Jul 11;16(7):e64316. doi: 10.7759/cureus.64316. eCollection 2024 Jul.
2
Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.匹莫范色林在临床实践中治疗帕金森病精神病性症状
Parkinsons Dis. 2021 Jan 4;2021:2603641. doi: 10.1155/2021/2603641. eCollection 2021.
3
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.普拉克索,一种血清素(2A)受体反向激动剂,用于治疗帕金森病精神病。
Neuropsychopharmacology. 2010 Mar;35(4):881-92. doi: 10.1038/npp.2009.176. Epub 2009 Nov 11.
4
Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.评估匹莫范色林或其他非典型抗精神病药物与帕金森病精神病患者死亡风险相关性的回顾性分析。
Clin Park Relat Disord. 2024 May 6;10:100256. doi: 10.1016/j.prdoa.2024.100256. eCollection 2024.
5
Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.帕金森病中的精神病:超越多巴胺治疗方法。
Curr Pharm Des. 2022;28(33):2725-2741. doi: 10.2174/1381612828666220428102802.
6
Pimavanserin in the Treatment of Parkinson's Disease Psychosis: Meta-analysis and Meta-regression of Randomized Clinical Trials.匹莫范色林治疗帕金森病精神病:随机临床试验的荟萃分析和荟萃回归
Innov Clin Neurosci. 2022 Jan-Mar;19(1-3):46-51.
7
Update on the treatment of Parkinson's disease psychosis: role of pimavanserin.帕金森病精神病治疗的最新进展:匹莫范色林的作用
Neuropsychiatr Dis Treat. 2017 Mar 8;13:737-744. doi: 10.2147/NDT.S108948. eCollection 2017.
8
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.匹莫范色林,一种用于治疗帕金森病精神病的新型抗精神病药物。
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1161-1168. doi: 10.1080/17512433.2017.1369405. Epub 2017 Oct 17.
9
Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.用 pimavanserin 改变帕金森病精神病的治疗模式。
Expert Rev Clin Pharmacol. 2019 Jul;12(7):681-691. doi: 10.1080/17512433.2019.1623669. Epub 2019 Jun 13.
10
Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis.使用匹莫范色林治疗帕金森病精神病的证据。
World J Psychiatry. 2019 Jun 10;9(3):47-54. doi: 10.5498/wjp.v9.i3.47.

本文引用的文献

1
Incidence of Parkinson disease in North America.北美帕金森病的发病率。
NPJ Parkinsons Dis. 2022 Dec 15;8(1):170. doi: 10.1038/s41531-022-00410-y.
2
Pimavanserin and Parkinson's Disease Psychosis: A Narrative Review.匹莫范色林与帕金森病精神病:一项叙述性综述。
Brain Sci. 2022 Sep 23;12(10):1286. doi: 10.3390/brainsci12101286.
3
Psychiatric Manifestation in Patients with Parkinson's Disease.帕金森病患者的精神症状。
J Korean Med Sci. 2018 Nov 1;33(47):e300. doi: 10.3346/jkms.2018.33.e300. eCollection 2018 Nov 19.
4
The Safety of Electroconvulsive Therapy in Patients With Implanted Deep Brain Stimulators: A Review of the Literature and Case Report.植入式脑深部电刺激器患者接受电休克治疗的安全性:文献综述与病例报告
J ECT. 2019 Jun;35(2):84-90. doi: 10.1097/YCT.0000000000000554.
5
Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.帕金森病精神病的管理:强调该病症的临床亚型和病理生理机制
Parkinsons Dis. 2017;2017:3256542. doi: 10.1155/2017/3256542. Epub 2017 Sep 12.
6
How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms.电休克疗法是如何起作用的?:理解神经生物学机制。
Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):210-221. doi: 10.9758/cpn.2017.15.3.210.
7
Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.帕金森病中的精神病:病因、现象学及管理综述
Drugs Aging. 2016 Dec;33(12):855-863. doi: 10.1007/s40266-016-0416-8.
8
Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.帕金森病性精神病作为一种5-羟色胺-多巴胺失衡综合征
CNS Spectr. 2016 Oct;21(5):355-359. doi: 10.1017/S1092852916000602.
9
Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy.在门诊电抽搐治疗重度抑郁症期间暂时中断深部脑刺激治疗帕金森病:一种新的治疗策略。
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):194-7. doi: 10.1176/jnp.23.2.jnp194.
10
Pathophysiology and treatment of psychosis in Parkinson's disease: a review.帕金森病中精神病的病理生理学与治疗:综述
Drugs Aging. 2008;25(8):665-82. doi: 10.2165/00002512-200825080-00004.